Heparin‐induced thrombocytopenia and recurrent thromboembolism

American Journal of Hematology

Volumn 8, Issue 3, 1980, Pages 325-332

  Ansell, Jack ^b   Deykin, Daniel ^a  

^a Veterans Administration Hospital   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

heparin; thrombocytopenia; thromboembolism

Indexed keywords

HEPARIN;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR SYSTEM; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

AGED; BLOOD PLATELETS; FEMALE; HEPARIN; HUMAN; MALE; MIDDLE AGE; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TIME FACTORS;

EID: 0019223160     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.2830080311     Document Type: Review

References (47)

1. The effect of heparin in vivo on the platelet count in mice and dogs
2. The effect of commerical heparin on the platelet count
3. Thrombocytopenia in rabbits induced by heparin, protamine, and polybrene
4. The effect of heparin on platelets in vivo
5. Heparin‐induced thrombocytopenia in man
6. Effect of injected heparin on platelet levels in man
7. Note on the effect of repeated intravascular injections of heparin
8. Influence of synthetic polysaccharid sulfuric acid esters on the thrombocytes in vivo and in vitro
9. Thrombocytopenic and related physiological effects of heparin and heparinoids: A macromolecular‐induced syndrome
10. The effects of intravenous administration of commerical beef heparin on the thrombocyte count and heparin sensitivity in man
11. Heparin‐induced thrombocytopenia
12. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations
13. Disseminated intravascular coagulation during heparin therapy
14. Heparin‐induced thrombocytopenia: Confirmation of diagnosis with in vitro methods
15. Heparin‐induced immune thrombocytopenia
16. Thrombocytopenia occurring during the administration of heparin
17. Thrombocytopenia during heparin therapy
18. Heparin and thrombocytopenia
19. Thrombocytopenia induced by low‐dose subcutaneous heparin
20. Heparin induced thrombocytopenia
21. Heparin immune thrombocytopenia: Evidence for a heparin‐platelet complex as the antigenic determinant
22. Thrombocytopenia in two patients treated with low‐dose heparin
23. Heparin‐related immune thrombocytopenia
24. Thrombocytopenia associated with antiheparin antibody
25. Heparin‐induced thrombocytopenia: Association with a platelet aggregating factor and arterial thrombosis
26. Heparin‐induced decrease in circulating antithrombin III
27. Heparin associated thrombocytopenia
28. Heparindusert trombocytopeni
29. Heparin‐associated thrombocytopenia: Low frequency in 104 patients treated with heparin of intestinal mucosal origin
30. Thrombocytopenia found uncommonly during heparin therapy
31. Heparin‐induced thrombocytopenia
32. In vitro studies of heparin‐associated thrombocytopenia
33. The platelet aggregating effect of eight commerical heparins
34. Arterial embolism occurring during systemic heparin therapy
35. Embolization of platelet agglutination thrombi in the hamster's pouch produced by heparin
36. White thromboembolism and vascular fragility in the hamster cheek pouch after anticoagulants
37. Elevated incidence of experimental thrombosis after heparin
38. Heparin – a cause of arterial emboli
39. Heparin reactions in patients with vascular disease
40. The dangers of intermittent intravenous heparin therapy
41. Peripheral arterial embolism
42. Fetal embolism despite low‐dose heparin
43. Fatal embolism despite heparin treatment
44. Arterial thromboembolism in patients receiving systemic heparin therapy
45. Heparin rebound
46. Heparin and thrombus formation: Early suppression and late enhancement